SANWA KAGAKU KENKYUSHO CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 1953-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.skk-net.com
Clinical Trials
63
Active:2
Completed:32
Trial Phases
3 Phases
Phase 1:9
Phase 2:9
Phase 3:37
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (57 trials with phase data)• Click on a phase to view related trials
Phase 3
37 (64.9%)Phase 1
9 (15.8%)Phase 2
9 (15.8%)phase_2_3
2 (3.5%)Phase 3 Study of SK-1403
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 153
- Registration Number
- NCT03801980
- Locations
- 🇯🇵
Investigational site (there may be other sites in this country), Tokyo, Japan
SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 157
- Registration Number
- NCT03626948
- Locations
- 🇯🇵
Investigational site (there may be other sites in this country), Tokyo, Japan
Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism
Phase 2
Completed
- Conditions
- Secondary Hyperparathyroidism
- Interventions
- Drug: Dose-adjusted SK-1403
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2019-03-15
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 58
- Registration Number
- NCT03226171
- Locations
- 🇯🇵
Investigational site (there may be other sites in this country), Tokyo, Japan
A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus
Phase 2
Completed
- Conditions
- Uremic Pruritus in Hemodialysis Patients
- Interventions
- Drug: SK-1405 low doseDrug: PlaceboDrug: SK-1405 high dose
- First Posted Date
- 2017-07-14
- Last Posted Date
- 2019-03-08
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 269
- Registration Number
- NCT03218501
- Locations
- 🇯🇵
Investigational site (there may be other sites in this country), Tokyo, Japan
Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2018-04-13
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 125
- Registration Number
- NCT03116191
- Locations
- 🇯🇵
Investigational site (there may be other sites in this country), Tokyo, Japan
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found